OrthoPediatrics appointed Kelly Fischer to its Board of Directors, succeeding Terry Schlotterback, effective August 8, 2025.
Quiver AI Summary
OrthoPediatrics Corp. has announced the appointment of Kelly Fischer to its Board of Directors, effective August 8, 2025, coinciding with Terry Schlotterback's retirement from the board. Mark Throdahl, Executive Chairman, expressed excitement about Fischer's financial expertise from her role as Senior Vice President and CFO at Cook Medical, which will support OrthoPediatrics' strategy in enhancing care for children with orthopedic needs. Fischer brings over two decades of experience in finance from Cook Medical and Ernst & Young and is committed to helping the company expand its impact in the pediatric orthopedic field. Founded in 2006, OrthoPediatrics focuses solely on pediatric orthopedics and offers over 80 products across various categories, with a global sales presence in over 70 countries.
Potential Positives
- The appointment of Kelly Fischer to the Board of Directors brings significant financial leadership experience from her role at Cook Medical, which could enhance OrthoPediatrics' strategic execution and expansion efforts.
- Kelly Fischer's commitment to leverage her experience to help OrthoPediatrics take market share and launch new technologies aligns with the company's mission to improve children's lives in pediatric orthopedics.
- The transition in leadership, with the retirement of Terry Schlotterback after over fifteen years, allows for fresh perspectives while maintaining continuity in OrthoPediatrics' strategic goals.
Potential Negatives
- Retirement of Terry Schlotterback as Chairman may signal instability or leadership changes that could impact company direction.
- The press release does not provide specific details about how Kelly Fischer's expertise will directly benefit the company's strategic initiatives, which may raise questions about the effectiveness of the Board's transition.
FAQ
Who has been appointed to the OrthoPediatrics Board of Directors?
Kelly Fischer has been appointed to the OrthoPediatrics Board of Directors effective August 8, 2025.
What position did Terry Schlotterback hold at OrthoPediatrics?
Terry Schlotterback served as a Director and Chairman of the Board for over fifteen years.
What is Kelly Fischer's role at Cook Medical?
Kelly Fischer is the Senior Vice President and Chief Financial Officer at Cook Medical.
What commitment does OrthoPediatrics have towards pediatric care?
OrthoPediatrics is dedicated to advancing pediatric orthopedics and improving children's lives through innovative products.
How many products does OrthoPediatrics currently market?
OrthoPediatrics markets over 80 products that serve various pediatric orthopedic categories.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$KIDS Insider Trading Activity
$KIDS insiders have traded $KIDS stock on the open market 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $KIDS stock by insiders over the last 6 months:
- FRED HITE (COO and CFO) has made 1 purchase buying 5,076 shares for an estimated $98,525 and 1 sale selling 6,443 shares for an estimated $160,172.
- DAVID R BAILEY (President and CEO) sold 6,620 shares for an estimated $164,573
- GREGORY A ODLE (President of Scoliosis) sold 5,359 shares for an estimated $133,224
- DANIEL J GERRITZEN (General Counsel and Secretary) sold 5,310 shares for an estimated $132,006
- JOSEPH W HAUSER (Pres. Trauma & Def. Correction) sold 5,300 shares for an estimated $131,758
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$KIDS Hedge Fund Activity
We have seen 49 institutional investors add shares of $KIDS stock to their portfolio, and 65 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WASATCH ADVISORS LP removed 402,223 shares (-56.0%) from their portfolio in Q2 2025, for an estimated $8,639,750
- GRANAHAN INVESTMENT MANAGEMENT, LLC added 299,771 shares (+44.9%) to their portfolio in Q2 2025, for an estimated $6,439,081
- HARBOR CAPITAL ADVISORS, INC. added 179,733 shares (+116.5%) to their portfolio in Q2 2025, for an estimated $3,860,664
- MORGAN STANLEY added 169,622 shares (+16.1%) to their portfolio in Q2 2025, for an estimated $3,643,480
- GOLDMAN SACHS GROUP INC removed 132,735 shares (-66.2%) from their portfolio in Q2 2025, for an estimated $2,851,147
- MILLENNIUM MANAGEMENT LLC added 124,449 shares (+19.0%) to their portfolio in Q2 2025, for an estimated $2,673,164
- BROWN CAPITAL MANAGEMENT LLC removed 113,821 shares (-6.8%) from their portfolio in Q2 2025, for an estimated $2,444,875
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$KIDS Analyst Ratings
Wall Street analysts have issued reports on $KIDS in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JMP Securities issued a "Market Outperform" rating on 08/08/2025
- Piper Sandler issued a "Overweight" rating on 05/08/2025
- Needham issued a "Buy" rating on 05/08/2025
- Lake Street issued a "Buy" rating on 04/07/2025
- Citizens Capital Markets issued a "Market Outperform" rating on 03/21/2025
- Stifel issued a "Buy" rating on 03/05/2025
To track analyst ratings and price targets for $KIDS, check out Quiver Quantitative's $KIDS forecast page.
$KIDS Price Targets
Multiple analysts have issued price targets for $KIDS recently. We have seen 8 analysts offer price targets for $KIDS in the last 6 months, with a median target of $36.0.
Here are some recent targets:
- David Turkaly from JMP Securities set a target price of $35.0 on 08/08/2025
- Ryan Zimmerman from BTIG set a target price of $39.0 on 08/06/2025
- Matt O'Brien from Piper Sandler set a target price of $30.0 on 05/08/2025
- Mike Matson from Needham set a target price of $42.0 on 05/08/2025
- Richard Newitter from Truist Securities set a target price of $24.0 on 04/11/2025
- Ben Haynor from Lake Street set a target price of $37.0 on 04/07/2025
- David Turkaly from Citizens Capital Markets set a target price of $50.0 on 03/21/2025
Full Release
WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to its Board of Directors effective as of August 8, 2025. The appointment was made concurrent with the announcement of the retirement of Terry Schlotterback from the OrthoPediatrics Board of Directors, effective as of August 8, 2025.
“We’re excited to welcome Kelly Fischer to the OrthoPediatrics Board of Directors. Her proven expertise in financial leadership at Cook Medical will be a significant asset as we execute our strategy and expand our impact on children’s lives,” said Mark Throdahl, Executive Chairman of the OrthoPediatrics Board of Directors. “At the same time, we extend our deepest appreciation to Terry for over fifteen years of leadership as a Director and Chairman of the Board. His unwavering service and dedication to the Company, along with his insight and guidance, have been instrumental in establishing OrthoPediatrics as a pioneer in the pediatric orthopedic space.”
OthoPediatrics’ newly appointed board member, Kelly Fischer, currently serves as the Senior Vice President and Chief Financial Officer of Cook Medical, a multibillion dollar medical device company. For over two decades at Cook Medical, Ms. Fischer has held roles of increasing responsibility in finance and operations. Prior to joining Cook Medical, Ms. Fischer was an Audit Manager at Ernst & Young and held various positions at Arthur Andersen. Ms. Fischer holds a bachelor’s degree in accounting from the Kelley School of Business at Indiana University.
“I am honored to join the OrthoPediatrics Board of Directors. The Company has demonstrated a steadfast commitment to the pediatric orthopedic field where it has advanced the standard of care since its inception,” said Kelly Fischer. “Leveraging my experience in the medical device industry, I am excited to support the strategy to help more kids by taking market share, launching new technologies and expanding the specialty bracing franchise in a capital efficient manner. It is a privilege to work alongside this talented team as we advanced towards helping one million kids.”
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 80 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com . For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com .
Investor Contact
Philip Trip Taylor
Gilmartin Group
[email protected]
415-937-5406
